Sequenom ($SQNM) sold off its Bioscience business to Agena Bioscience for $31 million. Through the deal, Agena gains access to Sequenom's MassArray System, a diagnostic tool that uses mass spectrometry to detect genetic biomarkers for cancer. Sequenom will receive up to $4 million in additional payments if MassArray meets certain regulatory and sales milestones, the company said in a statement. More